Pediatric Drug Development Process: A Review

References (32)

1. 1 Ten Common Questions (and Their Answers) About Off-label Drug Use [DOI]
2. 2 Pediatric Drug Formulations: A Review of Challenges and Progress [DOI]
3. 3 Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms [DOI]
4. 4 Formulations for children: problems and solutions [DOI]
5. 5 The Digital Pharmacies Era: How 3D Printing Technology Using Fused Deposition Modeling Can Become a Reality [DOI]
6. 6 Paediatric drug development: The impact of evolving regulations [DOI]
7. 7 Off-Label Prescribing: A Call for Heightened Professional and Government Oversight [DOI]
8. 8 Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence [DOI]
9. 9 Current Overview of Oral Thin Films [DOI]
10. 10 Acceptability of Uncoated Mini-Tablets in Neonates—A Randomized Controlled Trial [DOI]
11. 11 Approaches of 3D printing in current drug delivery [DOI]
12. 12 Pediatric Medicine Development: An Overview and Comparison of Regulatory Processes in the European Union and United States [DOI]
13. 13 Safety and Biopharmaceutical Challenges of Excipients in Off-Label Pediatric Formulations [DOI]
14. 14 Paediatric Drug Development and Formulation Design—a European Perspective [DOI]
15. 15 Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study [DOI]
16. 16 Methods of administering oral formulations and child acceptability [DOI]
17. 17 Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods [DOI]
18. 18 Paediatric Medicines in Europe: The Paediatric Regulation—Is It Time for Reform? [DOI]
19. 19 Novel milk-based oral formulations: Proof of concept [DOI]
20. 20 Fused Deposition Modeling (FDM) 3D Printing of the Thermo-Sensitive Peptidomimetic Drug Enalapril Maleate [DOI]
21. 21 Development of orally dissolving films for pediatric-centric administration of anti-epileptic drug topiramate – A design of experiments (DoE) study [DOI]
22. 22 The Current States, Challenges, Ongoing Efforts, and Future Perspectives of Pharmaceutical Excipients in Pediatric Patients in Each Country and Region [DOI]
23. 23 Recommendations on Off-Label Drug Use in Pediatric Guidelines [DOI]
24. 24 Challenges and strategies to facilitate formulation development of pediatric drug products: Safety qualification of excipients [DOI]
25. 25 Regulating off-label drug use in India: The arena for concern [DOI]
26. 26 Formulation development of chewable albendazole tablets with improved dissolution rate [DOI]
27. 27 Acceptability of Mebendazole Chewable Tablet in Children Aged 2 to 4 Years in Peru [DOI]
28. 28 How to identify and manage ‘problem’ excipients in medicines for children [DOI]
29. 29 Medicated straw: an innovative drug delivery system for paediatrics [DOI]
30. 30 Oral Bio Dissolving Films in Dentistry: A New Perspective in Treatment Modality
31. 31 International Journal of General Medicine [DOI]
32. 32 Turkish Journal of Pharmaceutical Sciences [DOI]

Cited by 4

Showing 1 of 4 known citations — external sources report more than can currently be individually listed.

Related research

• COP27 Making a Case for a Net Zero-Carbon Emissions Future by Implementing Technological Solutions and Mindset Transformation — shares topic coverage
• Exploring the Role of Robotic Automation in Climate Vulnerability Mitigation: Towards Sustainable Horticulture — shares topic coverage
• Questionable International Pediatric Studies in the United States and Russia Triggered by Regulatory Authorities — shares topic coverage